Member Info for 1509

Morning Nolupus
I watch an interview with Tim about the Sol cream. He mentioned about getting a partner to commercialise Sol.
I am aware that there have been a couple of RNS notices issued about sol.
What I dont know is if Sol has been through any of the phases to get approved to be used by the public or will this be a prescription cream?
As it is a cream what approval process does it need to go though?

On advfn Eva’s user name was Marie the account has also been deleted

EVA
Give us a sign

Surely Eva will be back
He/she has too many friends on this board.
If can feel the emails flying through to the admin of this site.
How very dare they delete Eva’s account

Lisa
If Tim wants to send me a Christmas card just let me know and I can e mail you my details

That’s a shame

Last communication I had with Eva she had had 2 bottles of wine
I feel sure she is watching over us.

Not the Nigerian order it has been approved by the Nigerian ministry of health

Not the Nigerian order it has been approved by the Nigerian ministry of health

The news about the MHRA approval is obviously important but lurking behind the scenes is VISITECT® CD4.
250000 unit order to Nigeria RNS 17 jan 2020
Rapid test approval is the icing on the cake but even so Omega has so much to offer

Score
Very good
Could not resist
Google translation of polyglot as I had not seen this word before
noun
a person who knows and is able to use several languages.

Interesting
I can’t help thing that the fda and Avion will have had a pre submission meeting during which they would have discussed the design and size of the trial and quite possibly informally agreed the basis of the trial.
Providing Avion submitted the SPA on the same basis as the previous meeting then surely approval subject to conditions is more than likely

Again doing a bit of searching and came across 2 reports which are not technical but give the current situation in simple terms. I would think that before the submission Avion would have had meetings with the FDA so when it went in there were no surprises. For me the approval seems to be a rubber stamp job the only questions are about the conditions the FDA will put on it
from sharecast.com:-
The AIM-traded firm said its licensing partner, Avion Pharmaceuticals, has submitted a special protocol assessment request to the US Food and Drug Administration (FDA).

It said the special protocol assessment process would see sponsors reach an agreement with the FDA on the design and size of clinical trials, so that they adequately address scientific and regulatory requirements for a study that could support marketing approval.

from IMM web site
Strong regulatory position
Lupuzor™ received Fast-Track designation from the US Food and Drug Administration (FDA), which expedites the drug’s approval process by shortening review periods. Lupuzor™ also received FDA approval to complete Phase III trial under Special Protocol Assessment (SPA) which effectively guarantees that the regulator will accept the trials’ results if they are positive.

Hopeingmore
I think waiting to see if your portfolio will peak at the same time so you see a nice balance is like waiting for a perfect storm.
Lovely if it happens and would put a big smile on my face

Safy
Nice post .
You have given good positive information about ODX.
On my feed for the ODX share price, NCYT come up as a comparison and some days when ODX are down you see NCYT surging ahead and I think have I backed the right horse?
Your post gives me confidence again to stick with ODX
Thanks

If it is close we can have a stewards inquiry
If Imm are up in the 20s I think we won’t be too bothered
Have a good weekend

Hi Eva
I see your point I have just checked some other platforms snd the prices for imm don’t appear to be up to date
Do if we use the site where you got 11.88 from for imm I presume this was the mid price.
Is this ok ?

HI Eva
On this board the ask and bid price are showing at 11.55 and 11.25.
The share price is showing at 11.3.
I just thought if we take the figures used on the respective boards it would give a consistent base price and it gives an easy to access reference point for people to check.

HI Bojo
Sclp on this board share price at close 16.125

For halfbutt IMM close share price as shown on LSE 11.3